Related by context. All words. (Click for frequent words.) 53 financialperformance 53 TSX VENTURE SHC 52 financialresults 52 resultsof 52 financialstatements 51 TSX VENTURE CMM 51 sNDA submission 51 TSX ELD AMEX EGO 50 NYSE PXP PXP 50 Hedgehog antagonist 50 unaudited consolidated balance sheets 50 IGXT IntelGenx today 49 Sedar.com 49 NYSE Amex AZK 49 eTag assays 49 unblind 48 aconference call 48 Nasdaq MAPP 48 SYMMETRY trial 48 NASDAQ GPCB today 47 NASDAQ BMTI 47 Company website http:/www.orl.co.il 47 TGA TransGlobe 47 results 47 SEMAFO TSX SMF 47 AMEX DDD 47 Domilens 47 TSX LUN OMX LUMI 47 GRAVITAS trial 47 NYSE ALJ Alon 47 Lauren Silvernail 47 www.radvision.com 47 OTCBB RDIAF announces 47 CEO Philip Verges 47 caustic fusion diamond 47 molecular biomarker 47 Dr. De Chirico 47 TASE CAMT 46 NYSE Amex SOQ 46 Inc. Nasdaq TELK 46 http:/www.smics.com 46 RESTORE CLI 46 Nasdaq ONXX today 46 TLR Timberline 46 brivaracetam 46 Company TSX WXI 46 Board TBIO 46 TSX BLU 46 DNA methylation markers 46 MelaFind pivotal 46 my3KG 46 www.lifepointhospitals.com 46 Cologuard 46 quarter# 46 NYSE Amex MFN 46 BUSINESS OUTLOOK 46 NASDAQ ARRY 45 AVGCF Avion 45 Inc. NASDAQ ARQL 45 Nasdaq PCYC 45 NYSE MIM MID 45 EAU Eldorado 45 Inc. Nasdaq EXEL 45 FIRST NORTH PXXS 45 APTIMA HPV assay 45 normalized FFO 45 LSE YAU 45 formal pharmacokinetic PK 45 #QSB 45 CLIRS trial 45 TSX VENTURE BLG 45 APEX AMI trial 45 NADiA ProsVue 45 MEND CABG 45 TSX GGC 45 Inc. Nasdaq LYTS 45 nonGAAP 45 Phase III ADT 45 www.ahtreit.com 45 CFO Hal Mechler 45 NYSE GRS Gammon 45 Corporation Nasdaq NVEC 45 OVA1 ® 44 OSLO QEC 44 TSX VENTURE MEX 44 www.Bunge.com 44 Company Nasdaq IMOS 44 Inc. NASDAQ ULTA 44 Inc. Nasdaq VASC 44 TSX VENTURE ABM 44 PillCam Colon 44 condensed consolidated interim 44 Preliminary Assessment Study 44 Company NASDAQ IMOS 44 Unicorp Annual Report 44 www.spec.org 44 pivotal bioequivalence 44 Inc. Nasdaq CRDN 44 Corporation Amex RIV 44 Inc. Nasdaq MSSR 44 EDEMA3 trial 44 alvespimycin 44 TSX OZN AMEX OZN 44 Nasdaq VRTX 44 website www.steinwaymusical.com 44 PDRT 44 Inc. NASDAQ TRMP 44 NASDAQ CLDX 44 CEO Jai Nagarkatti 44 PreGen Plus 44 www.cdw.com investor 44 Nasdaq NFLD announced 44 Nasdaq CYBE today 43 Scintillometer Readings 43 Inc. NASDAQ ALTH 43 Resverlogix Corp. Resverlogix 43 Phase 2b RESTORE CLI 43 TSX VENTURE AUN 43 AGI Alamos 43 nonclinical studies 43 Corp. NASDAQ JJSF 43 NYSE Euronext PHARM 43 Pervasip actual 43 FM LSE FQM 43 Repligen Corporation NASDAQ RGEN 43 QTinno TM 43 http:/www.sap.com/investor 43 Phase IIb III 43 unblinding 43 www.Limitedbrands.com 43 Relevant Triad Guaranty 43 Inc. NASDAQ BLUD 43 Eaglehead Property 43 NewHeights Software Corporation 43 Inc. Nasdaq CRZO 43 TSX ARZ AMEX AZK 43 Inc. Nasdaq ACOR 43 Inc. Nasdaq BIOD 43 TSX NI www.victorynickel.ca 43 Nasdaq GS BRNC 43 rALLy trial 43 seagate.com 43 restated financials 43 TASE CAMT announced 43 LungExpress Dx TM 43 bepotastine besilate nasal spray 43 Albert W. Ondis 43 NASDAQ SLXP today 43 CardioBip 43 Inc. NASDAQ HEPH 43 futureresults 43 BOVESPA TAMM4 43 Inc. NASDAQ NTMD 43 Patrick J. Balthrop 43 NYSE ETY 43 Genz # 42 Tesmilifene 42 QTinno ™ 42 MFFO 42 preclinical pharmacokinetic 42 www.mapleleaf.com 42 NYSE Amex ANV 42 Co. Nasdaq DBLE 42 TSX VENTURE SBB 42 CA9 SCAN 42 http:/www.nyseeuronext.com/ir 42 Inc. Nasdaq GHDX 42 NYSE Amex GSX 42 Inc. NASDAQ ACOR 42 preliminary metallurgical testwork 42 AVADO 42 pro forma adjusted EBITDA 42 non gaap 42 NYSE Amex TGB Taseko 42 #:# AM Central/# 42 TSX COM 42 Sean Roosen President 42 CLIRS 42 ChemoFx 42 TSX VENTURE GSH 42 http:/www.spec.org 42 Statutory Accounts 42 initiate Phase IIb 42 Company NYSE DRH 42 Inc. NASDAQ CRZO 42 TGP Frankfurt 42 Q4 CY# 42 Nasdaq NPSP announced 42 NASDAQ MFRI 42 condensed consolidated balance sheets 42 Inc. NASDAQ EXEL 42 Zybrestat 42 Inc. Nasdaq ZIPR 42 unaudited condensed 42 Inc. NASDAQ MIPI 42 www.isecuretrac.com 42 NYSE AMEX LCI 42 Genta Incorporated OTCBB 42 TSX VENTURE EXN 42 Inc. Nasdaq ALXA 42 AIM CMCL 42 unaudited Consolidated Statement 42 TSX VENTURE GOZ 42 Inc. NASDAQ NBIX 42 statements arebased 42 preclinically 42 www.omtr.com 42 OTCBB NSFDF FRANKFURT EFW 42 endoscopic gastric ulcers 41 www.ClinicalTrials.gov 41 SigmaTron 41 NYSE Amex AIS 41 R# #mg BID 41 DMEP 41 LE SN# 41 generation URAT1 inhibitor 41 ruxolitinib 41 QTinno 41 AMEX GRS 41 NASDAQ HYTM 41 andoperating 41 SEDAR EDGAR 41 NYSE VNR Vanguard 41 Company TSX ANV 41 www.genelogic.com 41 Nasdaq NYMX 41 GALNS 41 NASDAQ GEOI 41 www.liquidityservicesinc.com 41 BRIM3 41 Michael Klayko Brocade 41 www.chesapeakelodgingtrust.com 41 Fund TSX AIF.UN 41 BC SeraPro 41 interim unaudited consolidated 41 randomized Phase 2b 41 Corp. TSX LSG 41 SKVY 41 Non GAAP reconciliations 41 HORIZONS AMI trial 41 adopting SFAS #R 41 TASKi2 41 CHMP opinion 41 interim condensed consolidated 41 cannabinor 41 RAD SVT 41 http:/www.keryx.com 41 Flamel Technologies NASDAQ FLML 41 JEOM 41 Phase 1a clinical 41 sonographic findings 41 thefourth quarter 41 EGS# 41 AIM EGU TSX EGU 41 Inc. Nasdaq MDVN 41 Biophan anticipates 41 Ofer Segev executive 41 geochemical assay 41 Company NASDAQ FEIC 41 PCI ExTRACT TIMI 41 TASE ITRN 41 ClosureFAST catheter 41 attached unaudited condensed 41 Feasibility Study FS 40 CAE FY# 40 invoiced shipments 40 NMP# 40 AM Eastern Daylight 40 Norcraft Companies LP Norcraft 40 VESTASYNC 40 TSX PLS 40 trastuzumab DM1 T DM1 40 TSX VENTURE CFZ 40 http:/www.omtr.com 40 PROactive study 40 Solorel TM 40 TEMSO 40 http:/investor.verisign.com 40 SUCCEED trial 40 value www.bluefly.com 40 Albany Molecular AMRI 40 Paul Averback 40 netincome 40 CaPre TM 40 dry dockings 40 trastuzumab emtansine T DM1 40 NanoKnife IRE System 40 Inc. OTC CDCO 40 Inc. Nasdaq VRML 40 Pharmacokinetic parameters 40 VerifyNow P#Y# Test 40 Nasdaq MTOX 40 website www.mbandt.com 40 proration factor 40 un audited consolidated 40 upon Trevali metallurgical 40 TSX VENTURE ZED 40 Inc. NASDAQ CBRX 40 Inc. NASDAQ SNUS 40 resutls 40 Q2 FY# [001] 40 realizability 40 NYSE CJR 40 BREVAGen ™ 40 auditors PricewaterhouseCoopers LLP 40 preclinical efficacy 40 USD#.#m USD#.# per [002] 40 TOLAMBA 40 NASDAQ GS TRAD 40 #.# perdiluted 40 TSX BNK AIM BNK 40 AMR CORPORATION CONSOLIDATED 40 Nasdaq ALKS 40 Sensitivity analyzes 40 Summarized below 40 Ultimate Squeegee 40 Inc. NASDAQ MLNK 40 TSX VENTURE SDX 40 NYSE GIL 39 #Q filing 39 commented Kevin Hrusovsky 39 NYSE CHT Chunghwa 39 Statistical Supplement 39 Q1 FY# [001] 39 Inc. NASDAQ NXST 39 meta regression 39 unaudited consolidated interim 39 excludes nonrecurring items 39 NYSE HWD 39 IMPACT DCM 39 Clinical Diagnostics segment 39 Combination Transaction 39 tables summarize 39 TC AMEX TCX 39 TSX PMZ.UN 39 NYSE Amex TIS 39 Oncotype DX Recurrence Score 39 abstracts summarizing 39 SEQureDx 39 PITX2 methylation 39 marginally accretive 39 CUSTOM III 39 Nasdaq THRX 39 Discovery Labs KL4 39 Flow cytometry 39 NGNM 39 TSX ORE 39 Q4 LY 39 fi ndings 39 Core Hand Held 39 varespladib 39 initiate Phase 2b 39 iroxanadine 39 EBDDT 39 NASDAQ COHR 39 EPL EPL 39 AVERROES 39 Nasdaq CRDC 39 PROLARIS 39 Summarized consolidated 39 flotation testwork 39 Inc. Nasdaq ZGEN 39 Nyngan Scandium Project 39 Ampac ISP Corp. 39 ZYBRESTAT fosbretabulin 39 Nasdaq GPCB 39 differ materially fromthose 39 Tocosol Paclitaxel 39 AMEX ABL 39 Dr. Baim 38 AIM BNK 38 efficacy endpoint 38 IGM TSX IGM 38 Netas Mining 38 DCE MRI 38 SRK Consulting SRK 38 Inc. NASDAQ COHU 38 angiographic outcomes 38 endedSeptember 38 methylation markers 38 website www.minera irl.com 38 Reiterates Guidance 38 maydiffer materially 38 LEAPS construct 38 http:/investor.manpower.com 38 MacroChem actual 38 Items impacting comparability 38 EMPOWER TM 38 Inc. NASDAQ ADPI 38 PLCO trial 38 EPS Excl 38 budesonide MMX Phase III 38 Nasdaq SGMO announced 38 SEC Regulation FD 38 PARTNER Trial 38 TSX DNG 38 PRIMO CABG 38 Company website www.gcgaming.com 38 ITT ESI 38 www.lscc.com 38 TOFUTTI Announces 38 IIa clinical trial 38 R Nasdaq NTII 38 Supplemental Financials 38 Dick Alario Chairman 38 NYSE OSE RCL 38 ACCORD COPD 38 Thorough QT 38 SuperMedia specializes 38 invoiced shipment 38 pro forma 38 Inc. NYSE LUB 38 distort comparability 38 narrows Quick Facts 38 CEO Jussi Pesonen 38 Inc. EET.TSX 38 http:/investor.google.com/webcast.html 38 factorsthat 38 Inc. Nasdaq CPRX 38 Ligand judgment 38 Brunswick Timberlands 38 eTRAK 38 Cervista HPV HR 38 Timeshare segment 38 Maine Timberlands 38 Inc. NASDAQ LTRE 38 Amtech commented 38 Oncotype DX ® 38 SPIRIT FIRST 38 Non GAAP Consolidated Statements 38 accretion dilution 38 Schedules 2Q 38 microdiamond results 38 teriflunomide 38 accompanying condensed consolidated 38 TSX VENTURE DIB 38 NYSE Amex NXG 38 web site http:/www.nasd-law.com/documents/classvrIcy Cape 38 ACUITY trial 38 Inc GHDX 38 KIACTA ™ 38 reconciles GAAP 38 BioForce Nanosciences actual 37 Multivariable logistic regression 37 SS NOI helps 37 PROGENSA PCA3 assay 37 zotarolimus 37 AMWO 37 Q4 F# 37 http:/news.yahoo.com/polls 37 IMPROVE HF 37 Wytowno # 1 37 Significant assay 37 fidaxomicin Phase 3 37 HERmark assay 37 TSX VENTURE OYL CGX 37 preclinical pharmacology 37 thequarter 37 Randomized clinical trials 37 differ materiallyfrom those 37 efficiency ratio teb 37 Phase 2b randomized 37 ENHANCE study 37 Eltek commented 37 Inc. Nasdaq OPTR 37 GetGoal Phase III 37 Earnings Release Scheduled 37 SIMPADICO trial 37 TSX VENTURE GRR 37 Outpatient Setting 37 actualresults 37 ostarine 37 unaudited unconsolidated 37 TTF Therapy 37 BigString Corporation actual 37 Board INTZ Intrusion 37 Inc. Nasdaq RCKY 37 EMPOWER ™ 37 illumigene 37 www.apollogold.com 37 Clinicaltrials.gov 37 CLARITY study 37 ENDEAVOR III 37 drilling wireline logs 37 PRAGUE Komercni Banka 37 Q2 F# 37 Inc. Nasdaq BRKS 37 KIACTA TM 37 Corporation NASDAQ DENN 37 VersaFilm 37 NYSE IOC POMSoX 37 TSX BKP 37 commission Safwat Rashid 37 percutaneous cryoablation 37 BHEM surveys 37 ALJ Initial Determination 37 acronym INA 37 intravascular ultrasonography 37 fidaxomicin Phase 37 Siebel Systems Annual Report 37 Inc. Nasdaq CNSL 37 TSX LMA hereinafter 37 leach recoveries 37 ORAL Sync 37 ABSORB trial 37 various prepetition liabilities 37 Preliminary metallurgical 37 ALSYMPCA 36 IVS Associates 36 NASDAQ PAAS Pan 36 AGM.A 36 Oncotype DX breast cancer 36 Inc. NASDAQ VLCM 36 Including discontinued operations 36 viral kinetic 36 Bracketed figures 36 CreditWatch placements 36 CreditWatch listing 36 NASDAQ APPA specialty 36 TSMC #nm iPDK 36 riociguat 36 TSX PDL.WT AMEX 36 Oncotype Dx 36 suggest Roche Invirase 36 Significant mineralized intercepts 36 Regression analyzes 36 TSX IPL.UN 36 pharmacodynamic effects 36 Trust TSX CWT.UN 36 ACSI methodology 36 PEARL HF 36 Bio Analytical Measurement 36 clinical endpoints 36 International Nasdaq PRAI 36 cblproperties.com 36 downhole radiometric logging 36 AZCAR Announces 36 cabozantinib 36 radiographic outcomes 36 PAL AMEX PAL.WS 36 samalizumab 36 accompanying unaudited consolidated 36 website www.highlandfunds.com 36 Wireline logs 36 NASDAQ MERX 36 thirdquarter 36 initiate Phase 2a 36 NASDAQ VMED LSE VMED 36 Fabricated Products segment 36 continuingoperations 36 Farmstead Telephone 36 IV RSD# 36 F#Q# revenues 36 phase IIb study 36 enoximone 36 cutover readiness 36 Supplemental Schedules 36 confirmatory clinical 36 Quarter Fiscal 36 spokeswoman Roberta Alenius 36 causeactual results 35 normalized EPS 35 Cascade Microtech NASDAQ CSCD 35 Vocal Laboratories 35 TRY.B 35 Q4 FY# [001] 35 myocardial viability 35 OvaRex 35 EnPro consolidated 35 NPA spokesperson Tlali 35 ABCSG 35 VTEM airborne surveys 35 Kumar Anshumali 35 Broker Numis Securities 35 DNAWitness Y 35 thatwe 35 BLOOM Behavioral modification 35 Quarterly Statistical Supplement 35 adding AJAX widgets 35 authenticity Yng 35 GuideLiner catheter 35 Zacks Consensus Estimates 35 orthopedist Dr. Andrew Cosgarea 35 ENDEAVOR clinical 35 TABLE #.OS -#/# parent 35 Inc. NASDAQ MWIV 35 transrectal ultrasound 35 NiMin Legacy 35 expenses totaled Ps 35 acquired Brooks Eckerd 35 ENHANCE trial 35 numerical specificity 35 Inc. Nasdaq SIGI 35 CEO Rejean Robitaille 35 NLX P# 35 postoperative radiotherapy 35 B. Lynne Parshall 35 TSX Venture BCM 35 xxxi adverse tax 35 SCHEDULED TO PREMIERE 35 Hubbell Incorporated NYSE HUBA 35 PLAVIX R patent 35 Cash Dividend Declared 35 event reporting Clintrace 35 Markman Order 35 UroVysion 35 diluted EPS 35 phase IIa 35 FQ2 35 Buyer Fees 35 Adtegrity.com Reports 35 ILLUMINATE 35 CT perfusion 35 REVIVE TA 35 Multiple logistic regression 34 FFO Declines 34 www.results.nic.in 34 evaluating mipomersen 34 todiffer materially 34 NYSE IAG BOTSWANA 34 JS Whang Chief Executive 34 pelvic ultrasound 34 website www.fblfinancial.com 34 Pearson correlation coefficients 34 tumor histology 34 journal Resuscitation 34 Bancorp Nasdaq TBBK 34 elacytarabine 34 serologic tests 34 SPIRIT IV 34 TSX TCW 34 CAT IIM 34 spokesman Fritz Schmuhl 34 TSX PBG 34 Inc. NASDAQ PEDH 34 DSD Dairy segment 34 audited consolidated 34 blood serum biomarkers 34 audited financials 34 Detect Ready MRSA 34 heap leach amenability 34 TSX VENTURE OGR 34 APTIMA HPV 34 NYSE THI 34 ToGA 34 NASDAQ CRFT 34 http:/surveys.ap.org 34 gamma logs 34 Prepackaged Plan 34 Phase 2b monotherapy 34 HCV RESPOND 2 34 commented Sean Durfy 34 abysmal Shaiken 34 S. maltophilia 34 Inc. NASDAQ MGAM 34 earnigns 34 German Purity Laws 34 secondary efficacy endpoint 34 commercially exploitable mineralization 34 SIMPADICO 34 PC DAC Exendin 34 couldcause actual results 34 items affecting comparability 34 reaudit 34 FQ = fiscal 34 2nd Quarter Results 34 approvability 34 GVAX AML 34 http:/www.ap-gfkpoll.com 34 PRIMO CABG2 33 ECJ judgment 33 longitudinal cohort 33 Multivariate analysis 33 adjusted EPS 33 Preliminary Results 33 Corporation NASDAQ THFF 33 invariable expression 33 colleague Sana Inoue 33 5-fluorouracil/leucovorin 33 Tovaxin Phase IIb 33 NYSE KFS 33 EDITDA 33 pulp metallic 33 Chase Kishner 33 NYSE COG 33 Neose subsequent 33 KRAS status 33 Mechanistic studies 33 NBA Mock Drafts 33 reults 33 methylation biomarkers 33 F#Q# EPS ahead 33 Inc. NASDAQ SAFT 33 Alan Vituli Chairman 33 holes #WR# 33 Results Exceed Expectations 33 Qtrly Avg 33 adversely affect NetEase 33 un audited 33 journal Ophthalmology 33 plecanatide 33 fullyear 33 candidate blinatumomab MT# 33 aq q 33 Cogdell Spencer Earnings 33 NITON 33 GrowthWorks Proposal 33 Bechara findings 33 NASDAQ VRGY premier 33 leachability 33 Karnataka SSLC 33 RSD# IV 33 backtests 33 mSEPT9 33 Post hoc 33 Upper Garabagh conflict 33 E3/EU 33 DNAWitness Mito 33 renamed #mattress.com 33 Principled Technologies 33 findings 33 website www.rainyriverresources.com 33 atherosclerotic renal artery stenosis 33 RC2 NASDAQ RCRC 33 RIO Lipids 33 2Q FY# [002] 33 website www.harrisinteractive.com ir 32 Inc. Nasdaq CVCO 32 Vericept patent 32 Newspaper Audience Databank 32 Russ Knittel 32 Negative Symptom Scale PANSS 32 Quarter Results 32 spokesman Siamak Herawi 32 Format Discussion 32 Lanty Smith Wachovia 32 OCF margin 32 DAC unlocking 32 #QF# 32 Patrick Spratt KVH 32 Casa Berardi mine 32 www.torchmarkcorp.com 32 Prospective Plantings report 32 animal xenograft models 32 CDEL commented 32 believes EBDDT 32 arlen specter election 32 cash flows 32 Mohamed lawyer Gadeir 32 confirmatory 32 pharmacokinetic characteristics 32 Nasdaq UTHR 32 IPA SBRB 32 Evaporative Cooling segment 32 nonrandomized studies 32 semi variograms 32 ACCORD Lipid 32 adjudicative proceeding 32 CYP#C# genotype 32 bronchopulmonary dysplasia BPD 32 Ltd. NASDAQ GIII 32 Spanish federation RFEC 32 discussed NuroPro Power3 32 spokesman Terry Alberstein 32 Incidental findings 32 posttest 32 DMIST 32 Carol Meyrowitz TJX 32 Dengue Hemorrhagic Virus 32 microdiamonds 32 Quarter Fiscal Year 32 Floyd Landis urine 32 PreCISe 32 PubMatic AdPrice Index 32 earnings preannouncements 32 topical INCB# 32 looking statementsaEUR describe 32 SIX Estimates 32 transient elastography 32 Grouped Hockey 32 intraobserver 32 naltrexone bupropion 32 boldface disclaimer 32 Deikmann 32 lipoprotein profiles 32 gall bladder milking 32 Nigel Pendse author 32 Zvi Slonimsky CEO 32 mutational status 32 Results 32 Corp. NASDAQ ARKR 32 preliminary 32 Inc. NASDAQ MIGP 32 FCGR3A 32 virological response 31 patriotism Gration 31 PowerPoint presentation highlighting 31 bronchial lavage 31 options.Past performance 31 performance orachievements 31 ejaculatory function 31 noncardiac chest pain 31 TRADJENTA 31 Donald Loppnow 31 Northwater Market Neutral 31 metrics 31 operating EBIDA 31 EPS accretion 31 predictive validity 31 Michael Deikmann 31 platelet function 31 Tuvalu delegate 31 www.cbseresults.nic.in 31 Tain Constituency 31 F#H# 31 CBI distributive 31 VIENNA Austria Erste 31 LTRE 31 Isaack Hassan 31 Dr. Movsas 31 quaterly 31 completion 31 postoperative chemotherapy 31 pro forma financials 31 genomewide association studies 31 Power3 Alzheimer disease 31 exclude nonrecurring items 31 PointRoll delivers 31 sale THACs sale 31 Spokeswoman Jennifer Weyrauch 31 Rating Watches 31 AVN# Phase 31 Inc. Nasdaq MAXY 31 PGxHealth FAMILION 31 BHIVA 31 seat mile RASM 31 F1Q EPS 31 Company nanocrystalline materials 31 Mazin Shuaib 31 term prognosis Eisold 31 Hovnanian trims 31 SVR# 31 monoclonal gammopathy 31 robust F#Q# 31 NewAlliance stockholders 31 hoax Alderden 31 Zacks Estimate 31 NASDAQ DMAN 31 Sentiments soured 31 SS NOI 31 Meta analyzes 31 SEK#.#bn [002] 31 Cervista 31 Mr. Eishen 31 facial transplantation 31 F4Q EPS 31 NSABP C 31 theoverall 30 DeWyze raspy tone 30 Darby Holladay USDA 30 Presidential Election Petitions 30 MERIT ES 30 hole DDH# 30 locoregional recurrence 30 resuts 30 Earnings Release Attachments 30 CAPT scores 30 Western blot 30 Simulations Plus Reports 30 Evolving Rating Watch 30 F1Q 30 revascularisation procedures 30 recombinant PSMA vaccine 30 FQ4 30 SSNOI 30 retabulation 30 EquiTrend ® 30 incorrect actual 30 neurologic outcomes 30 SoFIE 30 Alzhemed 30 Anne Eisele 30 these Tumorgrafts closely 30 Swiss KOF leading 30 extreme fractiousness 30 Kalsaka mine 30 % 2bcars 30 closet Teerapop 30 Jeaneen death 30 www.essexpropertytrust.com 30 overestimate underestimate 30 rebased OCF growth 30 didanosine associated 30 Kerala SSLC 30 eWorld patent 30 guidance 30 correctly Rosoff 30 spokesman Roi Lachmanovitch 30 negative UNII balances 30 Hormone receptor 30 visit www.iaaf.org 30 tesmilifene Phase III 30 Injunctive relief 30 Sudan Ashraf Qazi 30 EULEX deployment 30 PM NETANYAHU 30 KRAS mutation status 30 prognostic indicators 29 perinatal outcomes 29 JPatrickBedell wrote 29 Subjecting prisoner abuse 29 event reporting Empirica 29 Democrat Vostal 29 F2Q 29 developments 29 www.omnicomgroup.com InvestorRelations 29 outcome 29 mission Akutsu 29 associate Vyacheslav Sokolenko 29 firstquarter 29 Third Quarter Results 29 AIPGMEE 29 re sults 29 Judge Leopold Borrello 29 Sino US textile 29 RISE FALL NEUTRAL 29 discusss 29 moot Brandfonbrener told 29 Preliminary Assessment PA 29 iniparib 29 Pavelec regained consciousness 29 BETAS 29 fourthquarter 29 midquarter 29 Everthing stays 29 Chest x rays 29 statements 29 Frankfurt TecDAX SOW 29 regression equations 29 Chairman Fazel Ahmad 29 factual determinations 29 EPS 29 Phagaphasvivat 29 prospectively stratified 29 seasonally slowest 29 Cluuz search 29 spokeswoman Nellika Little 29 ERELI Well 28 Crain Waldrop 28 Oven frying 28 Financial Results 28 operable node 28 snap Tavaris Jackson 28 suspend verifiably 28 InterMune CAPACITY trials 28 SCD HeFT 28 Jai Ho trustee Nirja 28 DanceCenter segment parody 28 Mike Basha P.Eng 28 constitutes patentable 28 quarterly 28 unaudited 28 projections 28 spokesman Jim Condelles 28 secondquarter 28 Homebuilder Lennar posts 28 intradialytic hypotension IDH 28 tweaks refinements 28 Carolinas PEC 28 Ashcroft recusal 28 Literacy Test OSSLT 28 Earnings Preview EBay 28 assigning probabilities 28 Eventual Kurdish 28 MEMPHIS Tenn. AutoZone 28 Annualizing 28 ICJ ruling 28 QT QTc interval 27 NASDAQ TWIN 27 CYP#D# genotype 27 PlaySpan patent 27 Chuck Boehlke 27 vilazodone Stedivaze 27 finalization 27 Mattingly telephoned 27 ELISpot 27 conduct 27 Neena Moorjani spokeswoman 27 Boergers lifelong Democrat 27 unappealable 27 thedecision 27 clinical meaningfulness 27 Ryad Mansour 27 pacings 27 spokesman Neal McGarity 27 finalities 27 subconscious biases 27 TEPJF 27 bacteriological samples